VanEck Biotech ETF (BBH US) stock market data APIs
166.0231
0.21(0.1%)
as of September 17, 2025
Try our APIs with
free plan!
VanEck Biotech ETF Financial Data Overview
Price chart is built with
Anychart
Prev. Close
166.0231
Open
166.2297
High
166.2297
Low
166.0231
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get VanEck Biotech ETF data using free add-ons & libraries
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
VanEck Biotech ETF News
New
iShares Nasdaq Biotechnology ETF declares quarterly distribution of $0.0828
* iShares Nasdaq Biotechnology ETF (NASDAQ:IBB [https://seekingalpha.com/symbol/IBB]) - $0.0828 [https://www.ishares.com/us/products/239699/]. * Payable Sep 19; for shareholders of record Sep 16; ...
USD/CNH heavy near 7.12, eyes 7.10 support – BBH
The Chinese Yuan (CNH) is testing key support as mixed August inflation data highlights China’s struggle with deflation. Analysts see scope for gradual currency appreciation to boost household spending and support growth, BBH FX analysts report.
Dovish Fed can put additional downward pressure on USD – BBH
The global bond market rout stretched into a second day, weighing on equities, boosting gold prices to new highs, and lifting US Dollar (USD) against most currencies. The bond market sell-off reflects genuine concerns over fiscal profligacy across Europe and the US, BBH FX analysts report.
Citi’s Drew Pettit: Stocks are seeing a ‘healthy reset,’ not cause for concern
[Reset Push Button] atakan Citigroup’s director of U.S. equity strategy Drew Pettit described recent market declines as a “healthy reset” rather than a reason for alarm. In an interview with C...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
